Table 6:
Universal CMV Screening Studies1
| Reference | Number Tested for cCMV | Number cCMV positive (% positive) |
|---|---|---|
| Current Study | 7670 | 35(0.5%) |
| Hildebrandt et al (1967)44 | 130 | 1 (0.8%) |
| Hanshaw et al (1968)45 | 280 | 6 (2.1%) |
| Birnbaum et al (1969)46 | 545 | 2 (0.03%) |
| Starr et al. (1970)47 | 2147 | 26 (1.2 %) |
| Melish et al (1973)48 | 1963 | 20 (1%) |
| Embil et al (1975)49 | 542 | 3 (0.5%) |
| Andersen (1979)50 | 3060 | 12 (0.4%) |
| Larke et al (1980)51 | 15,212 | 64 (0.4%) |
| Montgomery et al (1980)52 | 954 | 9 (0.9%) |
| Peckham et al (1983)53 | 14,200 | 42 (0.3%) |
| Kamada et al (1983)54 | 2,070 | 11 (0.5%) |
| Ahlfors et al (1984)55 | 10,328 | 50 (0.5%) |
| Stagno et al (1986)56 | 11,124 | 82 (0.7%) |
| Yow et al (1988)57 | 3,899 | 22 (0.6%) |
| Griffiths et al (1991)58 | 2,737 | 9 (0.3%) |
| Sohn et al (1992)59 | 514 | 6 (1.2%) |
| Fowler et al (1993)2 | 27,055 | 267 (1.0%) |
| Tsai et al (1996)60 | 1,000 | 18 (1.8%) |
| Luchsinger et al (1996)61 | 658 | 12 (1.8%) |
| Barbi et al (1998)62 | 1,268 | 6 (0.5%) |
| Boppana et al (1999)63 | 20,885 | 246 (1.2%) |
| Halwachs-Baumann et al (2000)64 | 5,867 | 13 (0.2%) |
| Schlesinger et al (2003)65 | 2,000 | 14 (0.7%) |
| Numazaki et al (2004)66 | 11,938 | 37 (0.3%) |
| Gaytant et al (2005)67 | 7,793 | 7 (0.09%) |
| Yamagishi et al (2006)68 | 1,176 | 2 (0.2%) |
| Barbi et al (2006)69 | 9,032 | 16 (0.2%) |
| Estripeaut et al (2007)70 | 317 | 2 (0.6%) |
| Foulon et al (2008)71 | 14,021 | 74(0.5%) |
| Engman et al (2008)72 | 6,060 | 12 (0.2%) |
| Endo et al (2009)73 | 1,010 | 2 (0.2%) |
| Boppana et al (2010)38 | 20,448 | 92 (0.5%) |
| Koyano et al (2011)74 | 21,272 | 66 (0.3%) |
| de Vries et al (2011)75 | 6,433 | 35 (0.5%) |
| Boppana et al (2011)76 | 34,989 | 177 (0.5%) |
| Paradiz et al (2012)77 | 2,841 | 4 (0.1%) |
| Barkai et al (2013)78 | 8,105 | 22 (0.3%) |
| Barkai et al (2014)79 | 9,845 | 47 (0.5%) |
| Waters et al (2014)80 | 1,044 | 2 (0.2%) |
| Pinninti et al (2015)81 | 73,239 | 266 (0.4%) |
| Yamaguchi et al (2017)82 | 23,368 | 60 (0.3%) |
| Leruez-Ville et al (2017)83 | 11,715 | 44 (0.4%) |
| Barlinn et al (2018)84 | 1,348 | 3 (0.2%) |
| Puhakka et al (2019)85 | 19,868 | 40 (0.2%) |
| Uchida et al (2020)86 | 4,125 | 9 (0.2%) |
| Yamada et al (2020)87 | 11,736 | 56 (0.5%) |
| Dollard et al (2021)16 | 12,554 | 56 (0.5%) |
| Total | 450,385 | 2107 (0.5%) |
Table modified from Figure 1 (Congenital CMV Prevalence by World Bank Income Level) Ssentongo et al. JAMA Network Open, 2021. 19